Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Comparison of (11)C-4DST and (18)F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.

Minamimoto R, Nakaigawa N, Nagashima Y, Toyohara J, Ueno D, Namura K, Nakajima K, Yao M, Kubota K.

Abdom Radiol (NY). 2016 Mar;41(3):521-30. doi: 10.1007/s00261-015-0601-y.

PMID:
27039323
2.

Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.

Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H.

BMC Cancer. 2016 Mar 5;16(1):185. doi: 10.1186/s12885-016-2219-z.

3.

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.

Nakaigawa N, Kondo K, Tateishi U, Minamimoto R, Kaneta T, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Kubota Y, Inoue T, Yao M.

BMC Cancer. 2016 Feb 8;16:67. doi: 10.1186/s12885-016-2097-4.

4.

Bilateral renal lymphoma: rapid recovery from an acute kidney injury after open renal biopsy.

Mitome T, Furuya K, Imano M, Osaka K, Yokomizo Y, Hayashi N, Nakaigawa N, Yamanaka S, Yao M.

Clin Case Rep. 2015 Oct 7;4(1):5-8. doi: 10.1002/ccr3.401. eCollection 2016 Jan.

5.

Impact of Accidental Tumor Incision During Laparoscopic Partial Nephrectomy on the Oncologic and Clinical Outcomes.

Ito H, Makiyama K, Kawahara T, Osaka K, Izumi K, Yokomizo Y, Nakaigawa N, Yamanaka S, Yao M.

Clin Genitourin Cancer. 2015 Nov 26. pii: S1558-7673(15)00312-2. doi: 10.1016/j.clgc.2015.11.013. [Epub ahead of print]

PMID:
26724862
6.

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.

Kawahara T, Fukui S, Sakamaki K, Ito Y, Ito H, Kobayashi N, Izumi K, Yokomizo Y, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Yao M, Miyamoto H, Uemura H.

Oncotarget. 2015 Oct 13;6(31):32169-76. doi: 10.18632/oncotarget.5081.

7.

Predictors of trifecta outcomes in laparoscopic partial nephrectomy for clinical T1a renal masses.

Osaka K, Makiyama K, Nakaigawa N, Yao M.

Int J Urol. 2015 Nov;22(11):1000-5. doi: 10.1111/iju.12893. Epub 2015 Aug 6.

PMID:
26251228
8.

Validation of a patient-specific simulator for laparoscopic renal surgery.

Makiyama K, Yamanaka H, Ueno D, Ohsaka K, Sano F, Nakaigawa N, Yao M, Kubota Y.

Int J Urol. 2015 Jun;22(6):572-6. doi: 10.1111/iju.12737. Epub 2015 Feb 26.

PMID:
25721949
9.

Mucinous cystadenoma of a horseshoe kidney: A case report and literature review.

Mitome T, Yao M, Udaka N, Fusayasu S, Izumi K, Osaka K, Hayashi N, Nakaigawa N, Nagashima Y, Kubota Y.

Can Urol Assoc J. 2015 Jan-Feb;9(1-2):E30-2. doi: 10.5489/cuaj.2211.

10.

[Pathological diagnosis of renal tumors: up to date].

Nagashima Y, Aoki I, Kondo K, Nakaigawa N, Kishida T, Miyagi Y, Yao M.

Rinsho Byori. 2014 Jun;62(6):568-77. Japanese.

PMID:
25151776
11.

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.

Kakizoe M, Yao M, Tateishi U, Minamimoto R, Ueno D, Namura K, Makiyama K, Hayashi N, Sano F, Kishida T, Kobayashi K, Noguchi S, Ikeda I, Ohgo Y, Taguri M, Morita S, Inoue T, Kubota Y, Nakaigawa N.

BMC Cancer. 2014 Jun 2;14:390. doi: 10.1186/1471-2407-14-390.

12.

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas.

Yao M, Murakami T, Shioi K, Mizuno N, Ito H, Kondo K, Hasumi H, Sano F, Makiyama K, Nakaigawa N, Kishida T, Nagashima Y, Yamanaka S, Kubota Y.

Cancer Med. 2014 Aug;3(4):845-54. doi: 10.1002/cam4.270. Epub 2014 May 26.

13.

Laparoscopic nephroureterectomy for adult patient with primary obstructive megaureter.

Osaka K, Makiyama K, Ohtake S, Yamanaka H, Sano F, Nakaigawa N, Kubota Y.

Case Rep Urol. 2013;2013:124710. doi: 10.1155/2013/124710. Epub 2013 Dec 22.

14.

[A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dubé syndrome treated with molecular-targeting agents].

Nakamura M, Yao M, Sano F, Sakata R, Tatenuma T, Makiyama K, Nakaigawa N, Kubota Y.

Hinyokika Kiyo. 2013 Aug;59(8):503-6. Japanese.

15.

[Vesical tuberculosis after Bacillus Calmette-Guerin intravesical instillation therapy for bladder cancer].

Ohtake S, Kawaji K, Nakaigawa N, Inayama Y, Kubota Y.

Hinyokika Kiyo. 2013 Jul;59(7):457-60. Japanese.

16.

aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms.

Kato S, Akimoto K, Nagashima Y, Ishiguro H, Kubota K, Kobayashi N, Hosono K, Watanabe S, Sekino Y, Sato T, Sasaki K, Nakaigawa N, Kubota Y, Inayama Y, Endo I, Ohno S, Maeda S, Nakajima A.

Pancreatology. 2013 Jul-Aug;13(4):360-8. doi: 10.1016/j.pan.2013.05.006. Epub 2013 May 22.

PMID:
23890134
17.

[Four cases of penile fracture].

Ohtake S, Nakaigawa N, Kubota Y.

Hinyokika Kiyo. 2013 Apr;59(4):251-5. Japanese.

18.

Nonfunctioning juxtaglomerular cell tumor.

Sakata R, Shimoyamada H, Yanagisawa M, Murakami T, Makiyama K, Nakaigawa N, Inayama Y, Ohashi K, Nagashima Y, Yao M, Kubota Y.

Case Rep Pathol. 2013;2013:973865. doi: 10.1155/2013/973865. Epub 2013 Mar 27.

19.

[A case of myocardiac metastasis of clear cell renal carcinoma successfully treated with sunitinib].

Tatenuma T, Yao M, Sakata R, Sano F, Makiyama K, Nakaigawa N, Nakayama T, Inayama Y, Kubota Y.

Hinyokika Kiyo. 2013 Feb;59(2):97-101. Japanese.

20.

Comparison of the loss of renal function after cold ischemia open partial nephrectomy, warm ischemia laparoscopic partial nephrectomy and laparoscopic partial nephrectomy using microwave coagulation.

Kawahara T, Sakata R, Kawahara K, Ito H, Miyoshi Y, Sano F, Nakaigawa N, Uemura H, Yao M, Kubota Y, Makiyama K.

Curr Urol. 2013 Jan;6(3):118-23. doi: 10.1159/000343524. Epub 2012 Dec 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk